2021
DOI: 10.7150/ijms.54468
|View full text |Cite
|
Sign up to set email alerts
|

Cedrus atlantica Extract Suppress Glioblastoma Growth through Promotion of Genotoxicity and Apoptosis: In Vitro and In Vivo Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(11 citation statements)
references
References 38 publications
0
11
0
Order By: Relevance
“…The data revealed that CAt improved the inhibitory effects of 5‐FU and showed that the combination of CAt and 5‐FU achieved better treatment effects than a single drug. Previous studies on glioblastoma showed that CAt enhanced the antiproliferative effects of temozolomide on DBTRG‐05MG and RG2 cells (Chang et al., 2021 ). Therefore, CAt may be a potentially effective antiproliferative drug or anticancer adjuvant agent combined with clinical drugs.…”
Section: Discussionmentioning
confidence: 97%
See 4 more Smart Citations
“…The data revealed that CAt improved the inhibitory effects of 5‐FU and showed that the combination of CAt and 5‐FU achieved better treatment effects than a single drug. Previous studies on glioblastoma showed that CAt enhanced the antiproliferative effects of temozolomide on DBTRG‐05MG and RG2 cells (Chang et al., 2021 ). Therefore, CAt may be a potentially effective antiproliferative drug or anticancer adjuvant agent combined with clinical drugs.…”
Section: Discussionmentioning
confidence: 97%
“…In the literature, the growth inhibition of C. atlantica is considered to be one of the mechanisms of its anticancer effects. For example, C. atlantica extracts have exhibited inhibitory activity against HepG2 and Mahlavu hepatocellular carcinoma (IC 50 values 27.09 and 33.57 μg/ml, respectively) (Huang et al., 2020 ), DBTRG‐05MG and RG2 glioblastoma (IC 50 value 46.59 and 47.96 μg/ml, respectively) (Chang et al., 2021 ), and K562 chronic myelogenous leukemia (IC 50 value 59.76 μg/ml) (Saab et al., 2012 ) cell lines. In our study, we observed that CAt significantly decreased cell proliferation in HT‐29 and CT‐26 (IC 50 values 31.21 and 19.77 μg/ml, respectively).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations